Sign Out
Sitagliptin phosphate may increase the levels/effects of Angiotensin-Converting Enzyme Inhibitors, Digoxin, Hypoglycemia-Associated Agents, Insulins, Sulfonylureas.
The levels/effects of Sitagliptin phosphate may be increased by Alpha-Lipoic Acid, Androgens, Guanethidine, Lumacaftor, Monoamine Oxidase Inhibitors, Pegvisomant, P-glycoprotein/ABCB1 Inhibitors, Prothioamide, Quinolones, Ranolazine, Salicylates, Selective Serotonin Reuptake Inhibitors.
The levels/effects of Sitagliptin phosphate may be decreased by Hyperglycemia-Associated Agents, Lumacaftor, P-glycoprotein/ABCB1 inducers, Quinolones, Thiazide and Thiazide-Like Diuretics.
Continue with Google